A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Cancer Drug News FDA approves mitomycin for low-grade upper tract urothelial cancer April 17, 2020 The Food and Drug Administration (FDA) approved mitomycin for adult patients with low-grade upper tract…